Table 2 Estimated annualised impact of using Floseal in 100 procedures
Outcome | Clinical | Economic (Associated cost savings) |
|---|---|---|
Acquisition costs | ||
Incremental cost of Floseal use | £(25,577) | |
Main model | ||
Complications | ||
Number of complications avoided (n) | 18.2 | £83,536 |
Operating theatre | ||
Cumulative theatre time saved (hours) | 40.3 | £63,969 |
Surgical revision | ||
No of surgical revisions for bleeding avoided (n) | 9.0 | £34,038 |
Transfusions | ||
No of transfusions avoided | 32.4 | £22,317 |
Overall cost reduction | – | £203,860 |
Supplementary model | ||
Hospital bed savings | ||
Number of ICU days avoided | 30.0 | £57,960 |
Number of extended stay bed days avoided | 51.7 | £21,965 |